- Psoriasis
- FDA approved injectable agent (Skyrizi) for individuals who have failed Cosentyx or Taltz
Clinical Trials Research
1 Willowbrook Road, Suite #2
Cromwell, CT 06416
Phone: (860) 316-4509
Fax: (860) 316-4175
Email: martin@centralctderm.com